Butyrylcarnitine

Butyrylcarnitine is an endogenous metabolite found in plasma. Elevated levels of Butyrylcarnitine are closely associated with abnormalities in lipid and energy metabolism. Butyrylcarnitine can serve as a diagnostic and prognostic indicator for certain diseases, such as heart failure and head and neck cancer[1][2].

Product Specifications

CAS Number

[25576-40-3]

Product Name Alternative

MK0364 (1R,2R)stereoisomer

UNSPSC

12352211

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cancer; Metabolic Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Butyrylcarnitine.html

Purity

99.96

Solubility

H2O : ≥ 100 mg/mL

Smiles

CCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O

Molecular Formula

C11H21NO4

Molecular Weight

231.29

References & Citations

[1]Cheng ML, et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol. 2015 Apr 21;65 (15) :1509-20.|[2]Li Y, et al. Causal association between blood metabolites and head and neck cancer: butyrylcarnitine identified as an associated trait for cancer risk and progression. Hereditas. 2025 Mar 14;162 (1) :36.